Impressive survival data with semimetronomic oral chemotherapy with old agents in heavily treated metastatic breast cancer patients

被引：0
|
作者：
Mutlu, H. [1 ,2 ]
Bozcuk, H. [1 ,2 ]
Ozdogan, M. [1 ,2 ]
Artac, M. [1 ,2 ]
Coskun, H. S. [1 ,2 ]
Kargi, A. [1 ,2 ]
Uysal, M. [1 ,2 ]
Savas, B. [1 ,2 ]
机构：
[1] Akdeniz Univ, Sch Med, TR-07058 Antalya, Turkey
[2] Selcuk Univ, Meram Sch Med, Konya, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1082
引用
收藏
页数：2
相关论文
共 50 条
  • [11] CLINICAL EXPERIENCE WITH METRONOMIC CHEMOTHERAPY IN HEAVILY PRETREATED METASTATIC BREAST CANCER PATIENTS
    Gavila, J.
    Guerrero, A.
    Ruiz, A.
    Climent, M. A.
    Poveda, A.
    Guillem, V.
    Ruiz, N.
    ANNALS OF ONCOLOGY, 2008, 19 : 74 - 74
  • [12] Chemotherapy options for patients suffering from heavily pretreated metastatic breast cancer
    Jerusalem, Guy
    Rorive, Andree
    Collignon, Joelle
    FUTURE ONCOLOGY, 2015, 11 (12) : 1775 - 1789
  • [13] LONG-TERM SURVIVAL OF PATIENTS TREATED WITH COMBINATION CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
    FALKSON, G
    TORMEY, DC
    CAREY, P
    WITTE, R
    FALKSON, HC
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (08) : 973 - 977
  • [14] Relationship between overall survival and surrogate measures in patients with metastatic breast cancer treated with chemotherapy
    Culakova, E.
    Poniewierski, M. S.
    Crawford, J.
    Dale, D. C.
    Lyman, G. H.
    CANCER RESEARCH, 2017, 77
  • [15] Metastatic breast cancer patients' preferences and expectations for oral chemotherapy
    Jaisle, Alyssa
    Fortune, Erica E.
    Jacobs, Jamie
    Saxton, Claire
    Ackourey, Jemeille
    Zaleta, Alexandra K.
    CANCER RESEARCH, 2021, 81 (04)
  • [16] Weekly Non-pegylated Liposomal Doxorubicin Chemotherapy in Heavily Pre-treated Patients with Metastatic Breast Cancer
    Masci, Giovanna
    Gandini, Chiara
    Zuradelli, Monica
    Losurdo, Agnese
    Torrisi, Rosalba
    Rota, Selene
    Gullo, Giuseppe
    Velutti, Laura
    Giordano, Laura
    Santoro, Armando
    ANTICANCER RESEARCH, 2013, 33 (10) : 4603 - 4609
  • [17] Combination chemotherapy with Cisplatin, etoposide, and ifosfamide as a salvage treatment in heavily pre-treated metastatic breast cancer patients
    Habbel, P.
    Kurreck, A.
    Schulz, C. -O.
    Neumann, C.
    Possinger, K.
    Eucker, J.
    ONKOLOGIE, 2013, 36 : 160 - 160
  • [18] Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective study.
    Jagiello-Gruszfeld, Agnieszka I.
    Meluch, Malgorzata
    Kunkiel, Michal
    Gorniak, Anna
    Majstrak-Hulewska, Anna
    Gorska, Katarzyna
    Konieczna, Aleksandra
    Nowecki, Zbigniew
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [19] Breast Cancer Subtype and Survival in Metastatic Patients Treated With Bevacizumab
    Torrejon Castro, D.
    Di Cosimo, S.
    Vidal, M.
    Gomez, P.
    Bellet, M.
    Saura, C.
    Perez-Garcia, J.
    Munoz, E.
    Baselga, J.
    Cortes, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S349 - S349
  • [20] Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens
    Cabel, Luc
    Carton, Matthieu
    Cheaib, Bianca
    Pierga, Jean-Yves
    Dalenc, Florence
    Mailliez, Audrey
    Levy, Christelle
    Jacot, William
    Debled, Marc
    Leheurteur, Marianne
    Desmoulins, Isabelle
    Lefeuvre, Claudia
    Goncalves, Anthony
    Uwer, Lionel
    Ferrero, Jean-Marc
    Eymard, Jean-Christophe
    Petit, Thierry
    Mouret-Reynier, Marie-Ange
    Perrocheau, Genevieve
    Piot, Irwin
    Perol, David
    Simon, Gaetane
    Lerebours, Florence
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (02) : 397 - 406
12345